Realistic illustration of long COVID patients improving from fatigue and brain fog via NAD+ supplement trial at Massachusetts General Hospital.
Image generated by AI

NAD+ supplement shows early promise for long COVID fatigue and brain fog

Reported by AI Image generated by AI Fact checked

A randomized controlled trial at Massachusetts General Hospital tested high-dose nicotinamide riboside, a vitamin B3 derivative, to boost NAD+ levels in people with long COVID. Although between-group differences were limited, participants who took the supplement for at least 10 weeks reported improvements in fatigue, sleep, mood, and some executive function measures compared with their own baseline, suggesting potential benefits for some individuals despite mixed overall results.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline